Celldex Therapeutics (CLDX) Q2 2021 Earnings

6MayConfirmed
Q2 2020
Q3 2020
Q4 2020
Q2 2021
-0.73
-0.61
-0.48
-0.36

Details

Expected EPS
N/A
Actual EPS
-0.42
Surprise EPS
-0.42
Surprise Percent
+∞%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.42 per share for Q2 2021.

0 Comments

Share your thoughts